Comparison of in vivo mutagenesis in the endogenous Hprt gene and the lacI transgene of Big Blue® rats treated with 7,12- dimethylbenz[a]anthracene

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 401, Issue 1-2, 1998, Pages 165-178

  Manjanatha, M G ^a   Shelton, S D ^a   Aidoo, A ^a   Lyn Cook, L E ^a   Casciano, D A ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

6 Thioguanine resistant; Big Blue rat; Hprt; lacI

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CARCINOGENICITY; CONTROLLED STUDY; FEMALE; MOLECULAR CLONING; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL; T LYMPHOCYTE; TRANSGENE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BACTERIAL PROTEINS; CARCINOGENS; CLONE CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI PROTEINS; FEMALE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; KINETICS; LYMPHOCYTES; MUTAGENESIS; RATS; RATS, INBRED F344; RATS, INBRED STRAINS; REPRESSOR PROTEINS; SPLEEN; TIME FACTORS;

ANIMALIA; RODENTIA;

EID: 0032486138     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(98)00006-2     Document Type: Article

References (42)

1. J.A. Gossen, W.L.F. deLeeuw, C.H.T. Tan, E.C. Zworthoff, F. Berends, P.H.M. Lohman, D.L. Knook, J. Vijg, Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo, Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 7971-7975.
2. S.W. Kohler, G.S. Provost, A. Fieck, P.L. Kretz, W.O. Bullock, J.A. Sarge, D.L. Putman, J.M. Short, Spectra of spontaneous and mutagen-induced mutations in the lad gene in transgenic mice, Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 7958-7962.
3. M.J. Dycaico, G.S. Provost, P.L. Kretz, S.L. Ransom, J.C. Moores, J.M. Short, The use of shuttle vectors for mutation analysis in transgenic mice and rats, Mutat. Res. 307 (1994) 461-478.
4. F.D. Bullock, M.R. Curtis, Spontaneous tumors in the rat, J. Cancer Res. 14 (1930) 1-15.
5. S. Young, R.C. Hallows, Tumors of the mammary gland, in: V.S. Turusov (Ed.), Pathology of Tumors in Laboratory Animals, Vol. 1, IARC, LYON (1973) pp. 31-73.
6. H.S. Zackheim, Tumors of the skin, in: V.S. Turusov (Ed.), Pathology of Tumors in Laboratory Animals, Vol. 1, IARC, Lyon, (1973) pp. 1-21.
7. M.J. Dycaico, G.R. Stuart, G.M. Tobal, J.G. de Boer, B.W. Glickman, G.S. Provost, Species-specific differences in hepatic mutant frequency and mutational spectrum among λ/lacI transgenic rats and mice following exposure to aflatoxin B1, Carcinogenesis 17 (1996) 2347-2356.
8. T.R. Skopek, K.L. Kort, D.R. Marino, Relative sensitivity of the endogenous Hprt gene and lacI transgene in ENU-treated Big Blue B6C3F1 mice, Environ. Mol. Mutagen. 26 (1995) 9-15.
9. T.R. Skopek, K.L. Kort, D.R. Marino, L.V. Mittal, D.R. Umbenhauer, G.M. Laws, S.P. Adams, Mutagenic response of the endogenous Hprt gene and lad transgene in benzo(a)pyrene-treated BB B6C3F1 mice, Environ. Mol. Mutagen. 28 (1996) 376-384.
10. J.C. Mirsalis, J.A. Monforte, R.A. Winegar, Transgenic animal models for measuring in vivo mutations, Annu. Rev. Toxicol. 35 (1994) 145-164.
11. V.E. Walker, N.J. Gorelick, J.L. Andrews, T.R. Craft, J.G. deBoer, B.W. Glickman, T.R. Skopek, Frequency and spectrum of ENU-induced mutation at the Hprt and lacI loci in splenic lymphocytes of exposed lad transgenic mice, Cancer Res. 56 (1996) 4654-4661.
12. D.-J. Zhan, R.H. Heflich, P.P. Fu, Molecular characterization of mutation and comparison of mutation profiles in the Hprt gene of CHO cells treated with benzo[a]pyrene trans-7,8-diol-anti-9,10-epoxide, 1-nitrobenzo[a]pyrene trans-7,8-diol-anti-9,10-epoxide, and 3-nitrobenzo[a]pyrene trans-7,8-diol-anti-9,10-epoxide, Environ. Mol. Mutagen. 27 (1996) 19-29.
13. C. Huggins, L.C. Grand, F.P. Brillantes, Mammary cancer induced by a single feeding of polynuclear hydrocarbons, and its suppression, Nature 189 (1961) 204-207.
14. D. Sinha, T.L. Dao, A direct mechanism of mammary carcinogenesis induced by DMBA, J. Natl. Cancer Inst. 53 (1974) 841-846.
15. A.G. Jabara, P.S. Anderson, Effects of progesterone on mammary carcinogenesis when various doses of DMBA were applied directly to rat mammae, Pathology 14 (1982) 313-316.
16. S. Holtzman, M. Meade, J.P. Stone, C.J. Shellabarger, Carcinogenic responses to chemical applied directly to rat mammary glands in situ, Carcinogenesis 6 (1985) 769-772.
17. C.J. Moore, W.A. Tricomi, M.N. Gould, Comparison of DMBA metabolism and DNA binding in mammary epithelial cells from three rat strains with different susceptibilities to mammary carcinogenesis, Carcinogenesis 9 (1988) 2099-2102.
18. E.L. Cavalieri, S. Higginbotham, N.V.S. Ramakrishna, P.D. Devanesan, R. Todorovic, E.G. Rogan, S. Salmasi, Comparative dose-response tumorigenicity studies of dibenzo{a, l}pyrene vs. DMBA, BP and two dibenzo{a, L}pyrene dihydrodiols in mouse skin and rat mammary gland, Carcinogenesis 12 (1991) 1939-1944.
19. M.G. Manjanatha, L.E. Lyn-Cook, S.J. Culp, F.A. Beland, R.H. Heflich, A. Aidoo, Lymphocyte mutant frequency in relation to DNA adduct formation in rats treated with tumorigenic doses of the mammary gland carcinogen DMBA, Mutat. Res. 357 (1996) 89-96.
20. R.H. Heflich, R.A. Mittelstaedt, M.G. Manjanatha, L.E. Lyn-Cook, A. Aidoo, DNA sequence analysis of Hprt mutations in lymphocytes from Sprague-Dawley rats treated with 7,12-dimethylbenz[a]anthracene, Environ. Mol. Mutagen. 28 (1996) 5-12.
21. M.G. Manjanatha, J.B. Chen, J.G. Shaddock, A.J. Harris, S.D. Shelton, D.A. Casciano, Molecular analysis of lacI mutations in Rat2™ cells exposed to DMBA: evidence for DNA sequence and DNA strand biases for mutation, Mutat. Res. 372 (1996) 53-64.
22. R.A. Mittelstaedt, M.G. Manjanatha, S.D. Shelton, L.E. Lyn-Cook, J.B. Chen, A.A. Aidoo, D.A. Casciano, R.H. Heflich, A comparison of the types of mutations induced by DMBA in the lacI and Hprt genes of Big Blue rats, Environ. Mol. Mutagen., 1997, in press.
23. A. Aidoo, L.E. Lyn-Cook, R.H. Heflich, E.O. George, D.A. Casciano, The effect of time after treatment, treatment schedule and animal age on the frequency of 6-thioguanine-resistant T-lymphocytes induced in Fischer 344 rats by N-ethyl-N-nitrosourea, Mutat. Res. 298 (1993) 169-178.
24. A. Aidoo, L.E. Lyn-Cook, R.A. Mittelstaedt, R.H. Heflich, D.A. Casciano, Induction of 6-thioguanine-resistant lymphocytes in Fischer 344 rats following in vivo exposure to N-ethyl-N-nitrosourea and cyclophosphamide, Environ. Mol. Mutagen. 17 (1991) 141-151.
25. R.J. Albertini, K.L. Castle, W.R. Borcherding, T cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood, Proc. Natl. Acad. Sci. U.S.A. 79 (1982) 6617-6621.
26. B.J. Rogers, G.S. Provost, R.R. Young, D.L. Putman, J.M. Short, Interlaboratory optimization and standardization of mutant screening conditions used for λ/lacI transgenic mouse mutagenesis assay (I), Mutat. Res. 327 (1995) 57-66.
27. S.P. Wright, Adjusted p-values for simultaneous inference, Biometrics 48 (1992) 1005-1013.
28. K.S. Tao, C. Urlando, J.A. Heddle, Comparison of somatic mutation in a transgenic vs. host locus, Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 10681-10685.
29. ± heterozygous mouse, Mutat. Res. 351 (1996) 67-77.
30. P.A. Lefevre, H. Tinwell, J. Ashby, Mutagenicity of the potent rat hepatocarcinogen 6BT to the liver of transgenic (lacI) rats: consideration of a reduced mutation assay protocol, Mutagenesis 12 (1997) 45-47.
31. A.T. Lee, C. DeSimone, A. Cerami, R. Bucala, Comparative analysis of DNA mutations in lacI transgenic mice with age, FASEB J. 8 (1994) 545-550.
32. P.J. Farabaugh, Sequence of the lacI gene, Nature 274 (1978) 765-769.
33. A. Knoll, D.P. Jacobson, H. Hishino, P.L. Kretz, K.S. Lundberg, J.M. Short, S.S. Sommer, Evidence that the pattern of spontaneous somatic mutation can differ dramatically with tissue type, Environ. Mol. Mutagen. 23 (1994) 32, Suppl 23.
34. J.G. Jansen, H. Vrieling, A.A. van Zeeland, G.R. Mohn, The gene encoding Hprt as target for mutational analysis: PCR cloning and sequencing of the cDNA from the rat, Mutat. Res. 266 (1992) 105-116.
35. R.S. Tan, E.H.Y. Chu, J.E. Sinsheimer, Molecular analysis of Hprt mutants induced by glycidyl-1-naphthyl ether in mouse spleen cells in vivo, Environ. Mol. Mutagen. 22 (1993) 71-77.
36. J. Cole, T.R. Skopek, Somatic mutant frequency, mutation rates and mutational spectra in the human population in vivo, Mutat. Res. 304 (1994) 33-105.
37. W.W. Piegorsch, A.C. Lockhart, B.H. Margolin, K.R. Tindall, N.J. Gorelick, J.M. Short, G.J. Carr, E.D. Thompson, M.D. Shelby, Sources of variability in data from lacI transgenic mouse mutation assay, Environ. Mol. Mutagen. 23 (1994) 17-31.
38. G.S. Provost, J.M. Short, Characterization of mutations induced by ethylnitrosourea in seminiferous germ cells of transgenic B6C3F1 mice, Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 6564-6568.
39. B.S. Shane, K.R. Tindall, Effect of partial hepatectomy on the mutant frequency of BP in the liver of C57BL/6 transgenic mice, Environ. Mol. Mutagen. 23 (1994) 61, Suppl 23.
40. J.J. Hayward, B.S. Shane, K.R. Tindall, M.L. Cunningham, Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene, Carcinogenesis 16 (1995) 2429-2433.
41. W.W. Piegorsch, B.H. Margolin, M.D. Shelby, A. Johnson, J.E. French, R.W. Tennant, K.R. Tindall, Study design and sample size for a lacI transgenic mouse mutation assay, Environ. Mol. Mutagen. 25 (1995) 231-245.
42. G.R. Stuart, N.J. Gorelick, J.L. Andrews, J.G. de Boer, B.W. Glickman, The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic animals, Environ. Mol. Mutagen. 28 (1996) 385-392.